Obermeyer Wealth Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.73M | Sell |
10,832
-19
| -0.2% | -$4.09K | 0.11% | 71 |
|
|
2026
Q1 | $2.36M | Buy |
10,851
+245
| +2% | +$54.3K | 0.11% | 69 |
|
|
2025
Q4 | $2.42M | Buy |
10,606
+104
| +1% | +$23.7K | 0.11% | 71 |
|
|
2025
Q3 | $2.43M | Sell |
10,502
-1,301
| -11% | -$265K | 0.11% | 65 |
|
|
2025
Q2 | $2.19M | Sell |
11,803
-12,006
| -50% | -$2.23M | 0.11% | 73 |
|
|
2025
Q1 | $4.99M | Buy |
23,809
+617
| +3% | +$120K | 0.27% | 49 |
|
|
2024
Q4 | $4.12M | Buy |
23,192
+4,491
| +24% | +$826K | 0.21% | 51 |
|
|
2024
Q3 | $3.69M | Buy |
18,701
+265
| +1% | +$49.5K | 0.2% | 52 |
|
|
2024
Q2 | $3.16M | Buy |
18,436
+363
| +2% | +$60.1K | 0.18% | 53 |
|
|
2024
Q1 | $3.29M | Buy |
18,073
+7,613
| +73% | +$1.31M | 0.19% | 49 |
|
|
2023
Q4 | $1.62M | Buy |
10,460
+120
| +1% | +$17.5K | 0.11% | 57 |
|
|
2023
Q3 | $1.54M | Buy |
10,340
+419
| +4% | +$61.5K | 0.11% | 53 |
|
|
2023
Q2 | $1.34M | Sell |
9,921
-316
| -3% | -$46.3K | 0.1% | 60 |
|
|
2023
Q1 | $1.63M | Sell |
10,237
-1,027
| -9% | -$157K | 0.12% | 57 |
|
|
2022
Q4 | $1.82M | Sell |
11,264
-270
| -2% | -$41.4K | 0.14% | 56 |
|
|
2022
Q3 | $1.55M | Sell |
11,534
-385
| -3% | -$55.2K | 0.13% | 56 |
|
|
2022
Q2 | $1.83M | Buy |
11,919
+677
| +6% | +$103K | 0.13% | 50 |
|
|
2022
Q1 | $1.82M | Sell |
11,242
-9
| -0.1% | -$1.31K | 0.11% | 53 |
|
|
2021
Q4 | $1.52M | Sell |
11,251
-16
| -0.1% | -$1.89K | 0.08% | 59 |
|
|
2021
Q3 | $1.22M | Sell |
11,267
-222
| -2% | -$25.4K | 0.07% | 64 |
|
|
2021
Q2 | $1.29M | Buy |
11,489
+684
| +6% | +$77K | 0.07% | 67 |
|
|
2021
Q1 | $1.17M | Buy |
10,805
+4,094
| +61% | +$438K | 0.07% | 67 |
|
|
2020
Q4 | $719K | Buy |
6,711
+165
| +3% | +$15.9K | 0.05% | 70 |
|
|
2020
Q3 | $573K | Sell |
6,546
-239
| -4% | -$22.5K | 0.04% | 77 |
|
|
2020
Q2 | $666K | Buy |
6,785
+127
| +2% | +$11.2K | 0.06% | 60 |
|
|
2020
Q1 | $507K | Sell |
6,658
-373
| -5% | -$31.8K | 0.05% | 66 |
|
|
2019
Q4 | $623K | Sell |
7,031
-283
| -4% | -$23.5K | 0.06% | 72 |
|
|
2019
Q3 | $554K | Sell |
7,314
-800
| -10% | -$54.8K | 0.05% | 72 |
|
|
2019
Q2 | $590K | Buy |
8,114
+503
| +7% | +$39.5K | 0.05% | 73 |
|
|
2019
Q1 | $613K | Sell |
7,611
-350
| -4% | -$28.6K | 0.06% | 66 |
|
|
2018
Q4 | $734K | Hold |
7,961
| – | – | 0.07% | 61 |
|
|
2018
Q3 | $753K | Buy |
7,961
+631
| +9% | +$59.8K | 0.06% | 62 |
|
|
2018
Q2 | $679K | Sell |
7,330
-344
| -4% | -$33.6K | 0.06% | 62 |
|
|
2018
Q1 | $726K | Sell |
7,674
-875
| -10% | -$96.1K | 0.07% | 60 |
|
|
2017
Q4 | $827K | Buy |
8,549
+1,564
| +22% | +$147K | 0.07% | 64 |
|
|
2017
Q3 | $621K | Sell |
6,985
-108
| -2% | -$8.22K | 0.05% | 72 |
|
|
2017
Q2 | $514K | Buy |
7,093
+234
| +3% | +$15.7K | 0.05% | 77 |
|
|
2017
Q1 | $447K | Sell |
6,859
-3,770
| -35% | -$237K | 0.04% | 87 |
|
|
2016
Q4 | $666K | Sell |
10,629
-700
| -6% | -$42.7K | 0.06% | 67 |
|
|
2016
Q3 | $715K | Hold |
11,329
| – | – | 0.07% | 63 |
|
|
2016
Q2 | $701K | Buy |
11,329
+2,208
| +24% | +$135K | 0.07% | 61 |
|
|
2016
Q1 | $521K | Sell |
9,121
-759
| -8% | -$42.3K | 0.05% | 72 |
|
|
2015
Q4 | $585K | Sell |
9,880
-602
| -6% | -$34.7K | 0.05% | 63 |
|
|
2015
Q3 | $570K | Buy |
10,482
+58
| +0.6% | +$3.77K | 0.06% | 63 |
|
|
2015
Q2 | $700K | Buy |
10,424
+255
| +3% | +$16.6K | 0.06% | 69 |
|
|
2015
Q1 | $595K | Hold |
10,169
| – | – | 0.05% | 84 |
|
|
2014
Q4 | $665K | Buy |
+10,169
| New | +$641K | 0.06% | 84 |
|
|
2013
Q3 | – | Sell |
-2,861
| Closed | -$118K | – | 61 |
|
|
2013
Q2 | $118K | Buy |
+2,861
| New | +$125K | 0.03% | 73 |
|
Other funds holding ABBV
Obermeyer Wealth Partners's ABBV Position: Q2 2026 in Review
Obermeyer Wealth Partners reduced its AbbVie (ABBV) stake by 0.18% in Q2 2026, selling an estimated $4.09K and leaving 10,832 shares worth $2.73M. The position accounts for 0.11% of the portfolio, ranked #71.
Obermeyer Wealth Partners first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.99M in Q1 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Obermeyer Wealth Partners held 10,832 shares of AbbVie worth $2.73M as of Q2 2026.
- Obermeyer Wealth Partners sold 19 AbbVie shares in Q2 2026, an estimated $4.09K.
- AbbVie made up 0.11% of Obermeyer Wealth Partners's portfolio in Q2 2026, its #71 holding.
- Obermeyer Wealth Partners first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- Obermeyer Wealth Partners's AbbVie position peaked at $4.99M in Q1 2025.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Obermeyer Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.